Results 151 to 160 of about 2,079,920 (381)

The purification and properties of ferritin from human serum [PDF]

open access: green, 1976
Mark Worwood   +3 more
openalex   +1 more source

Clinical characteristics and outcomes of adults with acute heart failure in a South African teaching hospital

open access: yesESC Heart Failure, EarlyView.
In this study of 406 adults admitted with acute heart failure, the overall in‐hospital mortality rate was 3.4%. Independent predictors of in‐hospital mortality included elevated neutrophil‐lymphocyte ratio, C‐reactive protein, and potassium levels, along with moderate or severe aortic regurgitation and lower diastolic blood pressure.
Umar G. Adamu   +2 more
wiley   +1 more source

Serum ferritin in children with thalassaemia regularly transfused [PDF]

open access: bronze, 1974
Elizabeth A. Letsky   +3 more
openalex   +1 more source

The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes

open access: yesEuropean Journal of Heart Failure, EarlyView.
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg   +17 more
wiley   +1 more source

Serum ferritin assay and iron status in chronic renal failure and haemodialysis. [PDF]

open access: bronze, 1975
Saadaq Adan Hussein   +5 more
openalex   +1 more source

Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR‐HF2‐DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials

open access: yesEuropean Journal of Heart Failure, EarlyView.
Differences in baseline characteristics between major trials of intravenous (IV) iron therapy in heart failure. LVEF, left ventricular ejection fraction; SGLT2, sodium–glucose cotransporter 2. Aims Prior randomized trials have reported conflicting evidence regarding the efficacy of intravenous (IV) iron in patients with heart failure with reduced ...
Stefan D. Anker   +44 more
wiley   +1 more source

Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura   +23 more
wiley   +1 more source

Baseline serum ferritin predicts myocardial iron uptake following intravenous iron therapy – a hypothesis‐generating study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract Aims Many patients with heart failure (HF) are iron‐deficient. Intravenous (IV) iron therapy improves symptoms and reduces hospitalizations for HF. Several mechanisms have been proposed, including myocardial iron repletion. However, it is unknown if serum iron markers predict the extent of this repletion.
Julio Nunez   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy